Total Payments
$48,142
2024 Payments
$8,237
Companies
24
Transactions
137
Medicare Patients
182
Medicare Billing
$13,789
Payment Breakdown by Category
Other$33,188 (68.9%)
Travel$6,331 (13.2%)
Food & Beverage$4,729 (9.8%)
Consulting$3,700 (7.7%)
Education$194.95 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $33,188 | 39 | 68.9% |
| Travel and Lodging | $6,331 | 31 | 13.2% |
| Food and Beverage | $4,729 | 58 | 9.8% |
| Consulting Fee | $3,700 | 7 | 7.7% |
| Education | $194.95 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Incyte Corporation | $23,418 | 55 | $0 (2024) |
| Ipsen Biopharmaceuticals, Inc | $16,946 | 35 | $0 (2024) |
| TerSera Therapeutics LLC | $3,233 | 11 | $0 (2022) |
| AbbVie Inc. | $1,408 | 4 | $0 (2021) |
| Advanced Accelerator Applications | $812.00 | 1 | $0 (2021) |
| Janssen Biotech, Inc. | $318.16 | 7 | $0 (2024) |
| Genentech USA, Inc. | $276.76 | 2 | $0 (2023) |
| Foundation Medicine, Inc. | $218.96 | 2 | $0 (2022) |
| Janssen Scientific Affairs, LLC | $186.63 | 3 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $148.21 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,237 | 26 | Incyte Corporation ($5,518) |
| 2023 | $11,161 | 36 | Incyte Corporation ($10,568) |
| 2022 | $9,247 | 27 | Incyte Corporation ($3,654) |
| 2021 | $19,497 | 48 | Ipsen Biopharmaceuticals, Inc ($12,939) |
All Payment Transactions
137 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Incyte Corporation | PEMAZYRE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,160.00 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 12/02/2024 | Incyte Corporation | PEMAZYRE (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 12/02/2024 | Incyte Corporation | PEMAZYRE (Drug) | Travel and Lodging | Cash or cash equivalent | $20.00 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 12/02/2024 | Incyte Corporation | PEMAZYRE (Drug) | Travel and Lodging | Cash or cash equivalent | $3.48 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $121.84 | General |
| 09/24/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $82.28 | General |
| Category: Oncology | ||||||
| 08/28/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $123.50 | General |
| Category: Oncology | ||||||
| 08/23/2024 | BeiGene USA, Inc. | TEVIMBRA (Drug) | Food and Beverage | In-kind items and services | $106.73 | General |
| Category: Oncology | ||||||
| 08/07/2024 | Genentech, Inc. | — | Food and Beverage | In-kind items and services | $112.52 | General |
| 07/25/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Odomzo (Drug), YONSA | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Oncology | ||||||
| 07/11/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $660.00 | General |
| Category: Oncology | ||||||
| 07/11/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $158.63 | General |
| Category: Oncology | ||||||
| 06/27/2024 | SEAGEN INC. | — | Education | In-kind items and services | $95.00 | General |
| 06/25/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug), Somatuline Depot | Food and Beverage | In-kind items and services | $98.35 | General |
| Category: Oncology | ||||||
| 05/28/2024 | Incyte Corporation | PEMAZYRE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,160.00 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 05/16/2024 | Incyte Corporation | PEMAZYRE (Drug) | Travel and Lodging | Cash or cash equivalent | $626.75 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 05/16/2024 | Incyte Corporation | PEMAZYRE (Drug) | Food and Beverage | Cash or cash equivalent | $89.95 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 05/14/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological), DARZALEX, TALVEY | Food and Beverage | In-kind items and services | $27.27 | General |
| Category: Oncology | ||||||
| 05/01/2024 | Incyte Corporation | PEMAZYRE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $145.00 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 04/25/2024 | Janssen Scientific Affairs, LLC | ERLEADA (Drug), BALVERSA, PIPELINE | Food and Beverage | In-kind items and services | $82.28 | General |
| Category: Oncology | ||||||
| 04/02/2024 | Incyte Corporation | PEMAZYRE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,160.00 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 03/21/2024 | Incyte Corporation | PEMAZYRE (Drug) | Travel and Lodging | Cash or cash equivalent | $926.49 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 03/21/2024 | Incyte Corporation | PEMAZYRE (Drug) | Food and Beverage | Cash or cash equivalent | $101.80 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 03/14/2024 | Janssen Biotech, Inc. | BALVERSA (Drug), ERLEADA, AKEEGA | Food and Beverage | In-kind items and services | $27.28 | General |
| Category: Oncology | ||||||
| 01/18/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $121.81 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 45 | 65 | $14,665 | $3,629 |
| 2022 | 2 | 46 | 71 | $15,823 | $3,898 |
| 2021 | 2 | 44 | 56 | $13,670 | $3,465 |
| 2020 | 2 | 47 | 60 | $13,912 | $2,798 |
Total Patients
182
Total Services
252
Medicare Billing
$13,789
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 30 | 45 | $8,685 | $2,194 | 25.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 15 | 20 | $5,980 | $1,435 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 27 | 51 | $9,843 | $2,462 | 25.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 19 | 20 | $5,980 | $1,436 | 24.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 23 | 27 | $8,073 | $2,014 | 24.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 21 | 29 | $5,597 | $1,451 | 25.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 27 | 38 | $7,334 | $1,487 | 20.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 20 | 22 | $6,578 | $1,311 | 19.9% |
About Terri Pollack, ARNP
Terri Pollack, ARNP is a Nurse Practitioner healthcare provider based in Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2011. The National Provider Identifier (NPI) number assigned to this provider is 1104112150.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Terri Pollack, ARNP has received a total of $48,142 in payments from pharmaceutical and medical device companies, with $8,237 received in 2024. These payments were reported across 137 transactions from 24 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($33,188).
As a Medicare-enrolled provider, Pollack has provided services to 182 Medicare beneficiaries, totaling 252 services with total Medicare billing of $13,789. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Miami, FL
- Active Since 06/28/2011
- Last Updated 01/24/2012
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1104112150
Products in Payments
- PEMAZYRE (Drug) $23,318
- SOMATULINE DEPOT (Drug) $10,982
- ONIVYDE (Drug) $4,085
- Xermelo (Drug) $3,233
- Onivyde (Drug) $1,879
- CREON (Drug) $1,388
- LUTATHERA (Drug) $832.03
- DARZALEX (Biological) $263.61
- FOUNDATIONONE (Device) $218.96
- ERLEADA (Drug) $186.63
- Lunsumio (Biological) $150.00
- PROVENGE (Drug) $145.38
- HEMLIBRA (Biological) $126.76
- BAVENCIO (Drug) $125.00
- REBLOZYL (Biological) $125.00
- LIBTAYO (Biological) $121.81
- TEVIMBRA (Drug) $106.73
- ZEJULA (Drug) $90.73
- Instinct (Device) $31.92
- BALVERSA (Drug) $27.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Miami
Haydee Kapin, Dnp, Arnp, Aocn, DNP, ARNP, AOCN
Nurse Practitioner — Payments: $97,304
Nurse Practitioner $97,304
Mr. Carlos Larrauri, Arnp, ARNP
Nurse Practitioner — Payments: $22,058
Nurse Practitioner $22,058
Martha Rostran, A.r.n.p, A.R.N.P
Nurse Practitioner — Payments: $15,209
Nurse Practitioner $15,209
Ana Harwood, Arnp, ARNP
Nurse Practitioner — Payments: $11,930
Nurse Practitioner $11,930
Wendy Kays, Arnp, ARNP
Nurse Practitioner — Payments: $10,690
Nurse Practitioner $10,690
Ginna Gonzalez, Arnp, ARNP
Nurse Practitioner — Payments: $10,612
Nurse Practitioner $10,612